메뉴 건너뛰기




Volumn 30, Issue 11, 2014, Pages 1444-1451

Perlecan Heparan Sulfate Proteoglycan Is a Critical Determinant of Angiogenesis in Response to Mouse Hind-Limb Ischemia

Author keywords

[No Author keywords available]

Indexed keywords

CD31 ANTIGEN; FIBROBLAST GROWTH FACTOR 2; HEPARAN SULFATE; MESSENGER RNA; PERLECAN; VASCULOTROPIN; PROTEOHEPARAN SULFATE; VASCULAR ENDOTHELIAL GROWTH FACTOR A, MOUSE; VASCULOTROPIN A;

EID: 84908478240     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cjca.2014.06.003     Document Type: Article
Times cited : (12)

References (29)
  • 1
    • 66749098832 scopus 로고    scopus 로고
    • Basement membrane proteoglycans: modulators par excellence of cancer growth and angiogenesis
    • Iozzo R.V., Zoeller J.J., Nystrom A. Basement membrane proteoglycans: modulators par excellence of cancer growth and angiogenesis. Mol Cells 2009, 27:503-513.
    • (2009) Mol Cells , vol.27 , pp. 503-513
    • Iozzo, R.V.1    Zoeller, J.J.2    Nystrom, A.3
  • 2
    • 0031657808 scopus 로고    scopus 로고
    • Matrix proteoglycans: from molecular design to cellular function
    • Iozzo R.V. Matrix proteoglycans: from molecular design to cellular function. Annu Rev Biochem 1998, 67:609-652.
    • (1998) Annu Rev Biochem , vol.67 , pp. 609-652
    • Iozzo, R.V.1
  • 3
    • 0344393418 scopus 로고    scopus 로고
    • Perlecan and tumor angiogenesis
    • Jiang X., Couchman J.R. Perlecan and tumor angiogenesis. JHistochem Cytochem 2003, 51:1393-1410.
    • (2003) JHistochem Cytochem , vol.51 , pp. 1393-1410
    • Jiang, X.1    Couchman, J.R.2
  • 4
    • 0037178732 scopus 로고    scopus 로고
    • Hyperplastic conotruncal endocardial cushions and transposition of great arteries in perlecan-null mice
    • Costell M., Carmona R., Gustafsson E., et al. Hyperplastic conotruncal endocardial cushions and transposition of great arteries in perlecan-null mice. Circ Res 2002, 91:158-164.
    • (2002) Circ Res , vol.91 , pp. 158-164
    • Costell, M.1    Carmona, R.2    Gustafsson, E.3
  • 5
    • 0028072345 scopus 로고
    • Abnormal expression of perlecan proteoglycan in metastatic melanomas
    • Cohen I.R., Murdoch A.D., Naso M.F., et al. Abnormal expression of perlecan proteoglycan in metastatic melanomas. Cancer Res 1994, 54:5771-5774.
    • (1994) Cancer Res , vol.54 , pp. 5771-5774
    • Cohen, I.R.1    Murdoch, A.D.2    Naso, M.F.3
  • 6
    • 3643129096 scopus 로고    scopus 로고
    • Antisense targeting of perlecan blocks tumor growth and angiogenesis invivo
    • Sharma B., Handler M., Eichstetter I., et al. Antisense targeting of perlecan blocks tumor growth and angiogenesis invivo. JClin Invest 1998, 102:1599-1608.
    • (1998) JClin Invest , vol.102 , pp. 1599-1608
    • Sharma, B.1    Handler, M.2    Eichstetter, I.3
  • 7
    • 0028579734 scopus 로고
    • Perlecan, basal lamina proteoglycan, promotes basic fibroblast growth factor-receptor binding, mitogenesis, and angiogenesis
    • Aviezer D., Hecht D., Safran M., et al. Perlecan, basal lamina proteoglycan, promotes basic fibroblast growth factor-receptor binding, mitogenesis, and angiogenesis. Cell 1994, 79:1005-1013.
    • (1994) Cell , vol.79 , pp. 1005-1013
    • Aviezer, D.1    Hecht, D.2    Safran, M.3
  • 8
    • 27744523670 scopus 로고    scopus 로고
    • Perlecan knockdown in metastatic prostate cancer cells reduces heparin-binding growth factor responses invitro and tumor growth invivo
    • Savore C., Zhang C., Muir C., et al. Perlecan knockdown in metastatic prostate cancer cells reduces heparin-binding growth factor responses invitro and tumor growth invivo. Clin Exp Metastasis 2005, 22:377-390.
    • (2005) Clin Exp Metastasis , vol.22 , pp. 377-390
    • Savore, C.1    Zhang, C.2    Muir, C.3
  • 10
    • 0030010512 scopus 로고    scopus 로고
    • Proteoglycans of the extracellular environment: clues from the gene and protein side offer novel perspectives in molecular diversity and function
    • Iozzo R.V., Murdoch A.D. Proteoglycans of the extracellular environment: clues from the gene and protein side offer novel perspectives in molecular diversity and function. FASEB J 1996, 10:598-614.
    • (1996) FASEB J , vol.10 , pp. 598-614
    • Iozzo, R.V.1    Murdoch, A.D.2
  • 11
    • 40749125285 scopus 로고    scopus 로고
    • Sustained VEGF blockade results in microenvironmental sequestration of VEGF by tumors and persistent VEGF receptor-2 activation
    • Kadenhe-Chiweshe A., Papa J., McCrudden K.W., et al. Sustained VEGF blockade results in microenvironmental sequestration of VEGF by tumors and persistent VEGF receptor-2 activation. Mol Cancer Res 2008, 6:1-9.
    • (2008) Mol Cancer Res , vol.6 , pp. 1-9
    • Kadenhe-Chiweshe, A.1    Papa, J.2    McCrudden, K.W.3
  • 12
    • 3142682314 scopus 로고    scopus 로고
    • Impaired angiogenesis, delayed wound healing and retarded tumor growth in perlecan heparan sulfate-deficient mice
    • Zhou Z., Wang J., Cao R., et al. Impaired angiogenesis, delayed wound healing and retarded tumor growth in perlecan heparan sulfate-deficient mice. Cancer Res 2004, 64:4699-4702.
    • (2004) Cancer Res , vol.64 , pp. 4699-4702
    • Zhou, Z.1    Wang, J.2    Cao, R.3
  • 13
    • 1542283679 scopus 로고    scopus 로고
    • Increased intimal hyperplasia and smooth muscle cell proliferation in transgenic mice with heparan sulfate-deficient perlecan
    • Tran P.K., Tran-Lundmark K., Soininen R., et al. Increased intimal hyperplasia and smooth muscle cell proliferation in transgenic mice with heparan sulfate-deficient perlecan. Circ Res 2004, 94:550-558.
    • (2004) Circ Res , vol.94 , pp. 550-558
    • Tran, P.K.1    Tran-Lundmark, K.2    Soininen, R.3
  • 14
    • 0037439268 scopus 로고    scopus 로고
    • Heparan sulfate chains of perlecan are indispensable in the lens capsule but not in the kidney
    • Rossi M., Morita H., Sormunen R., et al. Heparan sulfate chains of perlecan are indispensable in the lens capsule but not in the kidney. EMBO J 2003, 22:236-245.
    • (2003) EMBO J , vol.22 , pp. 236-245
    • Rossi, M.1    Morita, H.2    Sormunen, R.3
  • 16
    • 73249140173 scopus 로고    scopus 로고
    • Adenoviral transfer of HIF-1alpha enhances vascular responses to critical limb ischemia in diabetic mice
    • Sarkar K., Fox-Talbot K., Steenbergen C., Bosch-Marce M., Semenza G.L. Adenoviral transfer of HIF-1alpha enhances vascular responses to critical limb ischemia in diabetic mice. Proc Natl Acad Sci U S A 2009, 106:18769-18774.
    • (2009) Proc Natl Acad Sci U S A , vol.106 , pp. 18769-18774
    • Sarkar, K.1    Fox-Talbot, K.2    Steenbergen, C.3    Bosch-Marce, M.4    Semenza, G.L.5
  • 17
    • 34548269646 scopus 로고    scopus 로고
    • Assessment of ischemia-induced microvascular remodeling using contrast-enhanced ultrasound vascular anatomic mapping
    • Pascotto M., Leong-Poi H., Kaufmann B., et al. Assessment of ischemia-induced microvascular remodeling using contrast-enhanced ultrasound vascular anatomic mapping. JAm Soc Echocardiogr 2007, 20:1100-1108.
    • (2007) JAm Soc Echocardiogr , vol.20 , pp. 1100-1108
    • Pascotto, M.1    Leong-Poi, H.2    Kaufmann, B.3
  • 18
    • 33750886289 scopus 로고    scopus 로고
    • Perlecan: how does one molecule do so many things?
    • Knox S.M., Whitelock J.M. Perlecan: how does one molecule do so many things?. Cell Mol Life Sci 2006, 63:2435-2445.
    • (2006) Cell Mol Life Sci , vol.63 , pp. 2435-2445
    • Knox, S.M.1    Whitelock, J.M.2
  • 19
    • 84872180918 scopus 로고    scopus 로고
    • Perlecan maintains microvessel integrity invivo and modulates their formation invitro
    • Gustafsson E., Almonte-Becerril M., Bloch W., Costell M. Perlecan maintains microvessel integrity invivo and modulates their formation invitro. PLoS One 2013, 8:e53715.
    • (2013) PLoS One , vol.8 , pp. e53715
    • Gustafsson, E.1    Almonte-Becerril, M.2    Bloch, W.3    Costell, M.4
  • 20
    • 77956641177 scopus 로고    scopus 로고
    • Proteoglycans in health and disease: novel roles for proteoglycans in malignancy and their pharmacological targeting
    • Theocharis A.D., Skandalis S.S., Tzanakakis G.N., Karamanos N.K. Proteoglycans in health and disease: novel roles for proteoglycans in malignancy and their pharmacological targeting. FEBS J 2010, 277:3904-3923.
    • (2010) FEBS J , vol.277 , pp. 3904-3923
    • Theocharis, A.D.1    Skandalis, S.S.2    Tzanakakis, G.N.3    Karamanos, N.K.4
  • 21
    • 78049344435 scopus 로고    scopus 로고
    • Soluble perlecan domain I enhances vascular endothelial growth factor-165 activity and receptor phosphorylation in human bone marrow endothelial cells
    • Muthusamy A., Cooper C.R., Gomes R.R. Soluble perlecan domain I enhances vascular endothelial growth factor-165 activity and receptor phosphorylation in human bone marrow endothelial cells. BMC Biochem 2010, 11:43.
    • (2010) BMC Biochem , vol.11 , pp. 43
    • Muthusamy, A.1    Cooper, C.R.2    Gomes, R.R.3
  • 22
    • 67649367545 scopus 로고    scopus 로고
    • Perlecan regulates developmental angiogenesis by modulating the VEGF-VEGFR2 axis
    • Zoeller J.J., Whitelock J.M., Iozzo R.V. Perlecan regulates developmental angiogenesis by modulating the VEGF-VEGFR2 axis. Matrix Biol 2009, 28:284-291.
    • (2009) Matrix Biol , vol.28 , pp. 284-291
    • Zoeller, J.J.1    Whitelock, J.M.2    Iozzo, R.V.3
  • 23
    • 24744454378 scopus 로고    scopus 로고
    • Heparin regulates vascular endothelial growth factor 165-dependent mitogenic activity, tube formation, and its receptor phosphorylation of human endothelial cells
    • Ashikari-Handa S., Habuchi H., Kariya Y., Kimata K. Heparin regulates vascular endothelial growth factor 165-dependent mitogenic activity, tube formation, and its receptor phosphorylation of human endothelial cells. JBiol Chem 2005, 280:31508-31515.
    • (2005) JBiol Chem , vol.280 , pp. 31508-31515
    • Ashikari-Handa, S.1    Habuchi, H.2    Kariya, Y.3    Kimata, K.4
  • 24
    • 57149114934 scopus 로고    scopus 로고
    • HIP/RPL29 antagonizes VEGF and FGF2 stimulated angiogenesis by interfering with HS-dependent responses
    • D'Souza S., Yang W., Marchetti D., Muir C., Farach-Carson M.C., Carson D.D. HIP/RPL29 antagonizes VEGF and FGF2 stimulated angiogenesis by interfering with HS-dependent responses. JCell Biochem 2008, 105:1183-1193.
    • (2008) JCell Biochem , vol.105 , pp. 1183-1193
    • D'Souza, S.1    Yang, W.2    Marchetti, D.3    Muir, C.4    Farach-Carson, M.C.5    Carson, D.D.6
  • 25
    • 0025765459 scopus 로고
    • Altered distribution of basic fibroblast growth factor in diabetic retinopathy
    • Hanneken A., deJuan E., Lutty G.A., et al. Altered distribution of basic fibroblast growth factor in diabetic retinopathy. Arch Ophthalmol 1991, 109:1005-1011.
    • (1991) Arch Ophthalmol , vol.109 , pp. 1005-1011
    • Hanneken, A.1    deJuan, E.2    Lutty, G.A.3
  • 26
    • 0029851824 scopus 로고    scopus 로고
    • Immunohistochemical distribution of basic fibroblast growth factor in experimental retinal ischemia and reperfusion in the rat
    • Ohira A., de Juan E., Tano Y., Wilson C.A. Immunohistochemical distribution of basic fibroblast growth factor in experimental retinal ischemia and reperfusion in the rat. Histochem J 1996, 28:607-611.
    • (1996) Histochem J , vol.28 , pp. 607-611
    • Ohira, A.1    de Juan, E.2    Tano, Y.3    Wilson, C.A.4
  • 27
    • 0031659904 scopus 로고    scopus 로고
    • Basic fibroblast growth factor is neither necessary nor sufficient for the development of retinal neovascularization
    • Ozaki H., Okamoto N., Ortega S., et al. Basic fibroblast growth factor is neither necessary nor sufficient for the development of retinal neovascularization. Am J Pathol 1998, 153:757-765.
    • (1998) Am J Pathol , vol.153 , pp. 757-765
    • Ozaki, H.1    Okamoto, N.2    Ortega, S.3
  • 28
    • 0031768434 scopus 로고    scopus 로고
    • Targeted disruption of the FGF2 gene does not prevent choroidal neovascularization in a murine model
    • Tobe T., Ortega S., Luna J.D., et al. Targeted disruption of the FGF2 gene does not prevent choroidal neovascularization in a murine model. Am J Pathol 1998, 153:1641-1646.
    • (1998) Am J Pathol , vol.153 , pp. 1641-1646
    • Tobe, T.1    Ortega, S.2    Luna, J.D.3
  • 29
    • 0036892763 scopus 로고    scopus 로고
    • Targeted disruption of the Fgf2 gene does not affect vascular growth in the mouse ischemic hindlimb
    • Sullivan C.J., Doetschman T., Hoying J.B. Targeted disruption of the Fgf2 gene does not affect vascular growth in the mouse ischemic hindlimb. JAppl Physiol 2002, 93:2009-2017.
    • (2002) JAppl Physiol , vol.93 , pp. 2009-2017
    • Sullivan, C.J.1    Doetschman, T.2    Hoying, J.B.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.